Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

• DURBECQ V

収録刊行物

• Mol Cancer Ther

  Mol Cancer Ther 3 1207-1214, 2004

詳細情報

• CRID: 1572261550299767680
• NII論文ID: 10018767098
• データソース種別:
  • CiNii Articles